Delivery of subcutaneous immunoglobulin by rapid “push” infusion for primary immunodeficiency patients in Manitoba: a retrospective review

Abstract Background Both intravenous and subcutaneous human immune globin G (IgG) replacement (IVIG and SCIG, respectively) reduce severe infection and increase serum IgG levels in primary immune deficiency disorder (PIDD) patients who require replacement. SCIG can be administered either with the ai...

Full description

Bibliographic Details
Main Authors: Graham Walter, Chrystyna Kalicinsky, Richard Warrington, Marianne Miguel, Jeannette Reyes, Tamar S. Rubin
Format: Article
Language:English
Published: BMC 2020-05-01
Series:Allergy, Asthma & Clinical Immunology
Subjects:
IgG
Online Access:http://link.springer.com/article/10.1186/s13223-020-00431-3